In addition, we evaluated the expression of TOMM34 in clinical HCC samples by IHC analysis and found that TOMM34 was increased in samples with metastatic nodules (Fig 2M), which is consistent with results from GEO datasets (GSE3500; Fig EV2H). This evidence concerns the gene TOMM34 and hepatocellular carcinoma.